Publications
62
Citations
1,930
Est. group size
—
Recurring co-author estimate
Active years
19
Publishing since 2008
Jorge Rojas-Rivera studies kidney diseases caused by immune system dysfunction, with a particular focus on lupus nephritis (kidney inflammation from lupus) and membranous nephropathy (an autoimmune kidney disorder). His work spans clinical trials, biomarker studies, consensus treatment guidelines, and analyses of kidney biopsy data to improve diagnosis, monitoring, and treatment of these conditions.
Publication output has grown from sporadic single papers in 2017-2019 to a steadier pace of 2-5 papers per year since 2020, suggesting a growing and active research output over the past decade.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International · 2026
- Clinical Remission as a Function of Exposure to Cyclophosphamide in Patients with Primary Membranous Nephropathy: A One-Year Cohort Study
Glomerular Diseases · 2026
- Identification of early predictors of clinical remission in primary membranous nephropathy: a <i>post hoc</i> analysis of the STARMEN trial
Clinical Kidney Journal · 2025
- Encuesta GLANCE: conocimiento e implementación de las recomendaciones del documento de GLOSEN para el diagnóstico y tratamiento de la nefritis lúpica
Nefrología · 2025
- Profiling a Large Cohort of Patients with Lupus Nephritis Managed at a Safety-Net Hospital in Mexico City
Journal of the American Society of Nephrology · 2025
- GLANCE survey: awareness and implementation of the GLOSEN recommendations for the diagnosis and treatment of lupus nephritis
Nefrología (English Edition) · 2025
- Clinical and Histopathological Characteristics of Kidney Biopsies in a Tertiary Care Hospital in Mexico, 2012-2024: Temporal Trends and Diagnostic Patterns
Journal of the American Society of Nephrology · 2025
- Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort
Clinical Kidney Journal · 2024
- Noninvasive Assessment of the Presence or Absence of Histologic Activity in Kidney Biopsies from Patients with Lupus Nephritis
Journal of the American Society of Nephrology · 2024
- Modeling Chronic Damage in Lupus Nephritis Kidneys Noninvasively
Journal of the American Society of Nephrology · 2024
- Novel Treatments Paradigms: Membranous Nephropathy
Kidney International Reports · 2023
- Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN)
Clinical Kidney Journal · 2023
- Chronic kidney disease: the missing concept in the 2019 EULAR/ERA-EDTA recommendations for lupus nephritis
Nephrology Dialysis Transplantation · 2023
- Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis
Nefrología (English Edition) · 2023
- Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy
Nephrology Dialysis Transplantation · 2023
- Clinical Kidney Journal×6
- Journal of the American Society of Nephrology×5
- Kidney International×4
- Nephrology Dialysis Transplantation×4
- Nefrología (English Edition)×2
- Clarissa A. Cassol
Medicine · The Ohio State University
- Isabelle Ayoub
Medicine · The Ohio State University
- Mahmoud Kallash
Medicine · The Ohio State University
- Brad H. Rovin
Medicine · The Ohio State University
- Salem Almaani
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile